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BOTULISM: A LABORATORY INVESTIGATION ON BIOLOGICAL AND FOOD SAMPLES FROM CASES
AND OUTBREAKS IN BRAZIL (1982-2001)(1)
Dilma Scala GELLI(2), Miyoko JAKABI(2) & Aldo de SOUZA(3)
SUMMARY
Laboratory investigation of botulism from 1982 to 2001 confirmed the occurrence of eight positive outbreaks/cases of botulism
in Brazil. From those, type A botulism was observed in seven of them. Biological material of one case (serum and feces) was positive
in the first step of the bioassay, but the amount of sample was not sufficient for typification. One of the outbreaks that occurred in
2001 was negative for botulinum toxin in samples of serum, gastric washing and feces, collected eight days before the onset of the
symptoms in the affected person who was clinically diagnosed as presenting the disease. Other two cases presenting compatible
clinical diagnoses presented negative results. However, in those cases, the collection of samples was (1) after antiserum administration
or (2) later than eight days of the onset of symptoms. Investigation was performed by mouse bioassay, as described in the Compendium
of Methods for the Microbiological Examination of Foods (compiled by American Public Health Association – APHA)11, using
specific antiserum from Centers for Disease Control (CDC), USA.
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INTRODUCTION
Botulism is a disease caused by toxins produced by Clostridium
botulinum. This sporeformer anaerobic bacterium is naturally present in
different environments such as soil, sediment of superficial water, fresh
vegetables and spices. It can be isolated from different kinds of foods of
animal and vegetable origin5,9,10,15,23. Four biological groups and eight
types (A, B, C1, C2, D, E, F, and G) are recognized5, 9,10,17,23, based on
structural features, proteolytic activity and distinct antigenic toxins. There
are evidences that toxin production is either mediated by a prophage
(C1, D) or a plasmid (G)17,23. Non-toxigenic strains are found in nature5,23,
and a strain that produces both type A and B toxins23 has already been
isolated. Type A and some type B and F strains are proteolytic; type E,
saccharolytic type B and F are non-proteolytic strains.
There are many intrinsic and extrinsic factors that may affect the
growth of this bacterium in foods: it is a poor competitor when other
autochthon microorganisms are present in the product; acid pH and some
acidulants may inhibit or suppress its multiplication; water activity (Aw)
under 0.93 is limitant, and the inactivation response at different high
temperatures, as well to gamma irradiation treatment, is variable among
vegetative cells and spores of different strains. Multiplication of
proteolytic strains is inhibited at temperatures above 10 0C, and that of
non-proteolytic strains, above 3.3 0C3,4,5,7,8,9,10,13,20,23.
Types A, B, E and more rarely F, are related with human cases of
botulism; type G may cause disease in primates, what indicates the
possibility of affecting men5,18,23. Types A, B and F are mainly found in
soils and the intestinal tract of terrestrial animals; type E is found in
marine aquatic environment5,9,11,13,15,21,22,23.
Four categories of botulism are recognized: classical or foodborne,
due to ingestion of preformed toxin in foods; wound botulism due to
production of toxin in vivo, in the infected wound; infant botulism due
to C. botulinum colonization of the intestinal tract, in the absence of
natural microbiota (children 3-6 months old) and undetermined botulism,
involving persons in which no food or wound source is detected, and
that may be also related with colonization of the intestines2. Symptoms
in the affected person are similar in all categories and include generalized
muscular weakness, visual disturbance, difficulty in speaking, extremely
dry mouth, breathing difficulty, leading to respiratory failure, palpebral
ptosis, dysphonia and urinary retention. At the beginning of the signs,
intestinal manifestations may occur, including nausea, vomiting and
severe constipation, what may be followed or not by transitory diarrhea.
Depending on the amount of toxin and the category of disease, sudden
onset of symptoms may occur or not1,9,14,16,18,19,23. Outbreaks have been
described in all continents. Although botulism is a relative rare disease,
case fatality is high; from 1899 to 1995, 1,026 outbreaks were identified
in the USA, involving 2,444 cases and 1,040 deaths20. In Argentine,
according to ESCARTÍN (2000), 16 outbreaks were described from 1980
to 1989: 77% caused by type A, 8% by B, and 0% by E, involving 36
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affected persons, and 11 deaths. In the period between 1971 and 1989,
272 outbreaks were reported in the United States; 61% caused by type
A, 21% by B and 17% by type E, with 597 cases and 11 deaths. In
France, from 1978 to 1989, 175 (0% A, 97% B and 2% E) outbreaks
were reported, with 304 cases and 2 deaths. In Denmark, in the 1984-89
period, there were 11 outbreaks (0% A and B, and 100% E) with 16
cases and 12 deaths. Data available from these outbreaks indicate that
fruits and vegetables by-products are common vehicles for botulism. In
Argentine, fruit and vegetables by-products were responsible for 36%
of the cases, compared with 29% due to meats and 21% due to fish. In
the USA, among 294 outbreaks (1973-97), 128 were due to vegetable-
based foods, 47 due to fish, 5 due to mushrooms, 5 due to no lacteous
beverages, 16 due to meat-based foods, 3 due to Mexican style food, 47
related other kinds of foods and 43 were not identified5.
Botulinum toxins are thermolabile exoproteins (single dichain
molecule of polypeptide, with molecular weight of approximately 150
Mdaltons). Produced as a pro-toxin, the toxic fraction is released by
protease action; proteolytic strains can promote this release alone. For
the non-proteolytic strains, the action of exogenous proteases, such as
trypsin, is necessary. The toxin reaches the bloodstream and is
disseminated into the body. No matter if ingested or produced in vivo,
the toxin circulates in the body for 8-10 days after its release in
bloodstream. Botulinum toxins are considered neurotoxins and their
specific site of binding is the pre-synaptic cholinergic nerve in the muscle.
Symptoms are associated with the blockage of acetylcholine release at
the binding site of the toxin and the triggering of skeletal muscle
contraction16,17,18,23.
Antitoxin administration do not release the toxin bound to the nervous
terminal, but it is able to inactivate toxin circulating in the bloodstream,
i.e., it prevents further binding of toxin and consequent exacerbation of
symptoms. It is important to note that antitoxin administration does not
lead to remission of symptoms already present. The illness may have a
prolonged course, depending on the amount of bound toxin and may
persist for more than 6 months5,16,17,23.
Laboratorial investigation of cases and outbreaks of foodborne
botulism is based on the evidence of toxin in biological samples collected
from the affected person (serum, feces, gastric washing and other
specimens) and leftovers of ingested foods. Extraction of the toxin is
necessary in all kinds of samples, except serum. This is done by
maceration in phosphate gel, overnight maintenance under refrigeration,
followed by centrifugation. The supernatant is separated in three portions,
in order to perform a presumptive laboratorial diagnosis. This first step
is carried out for the demonstration of (1) the presence of the active
substance that does not require trypsin activation (untreated portion);
(2) the thermolabile characteristic (heat-treated portion); and (3) the
presence of the pro-toxin (trypsin-treated portion). When (1) and/or (3)
are positive, the definitive diagnostic step is the determination of the
type of toxin, by inactivation with specific antiserum. The most reliable
and sensitive method is the mouse bioassay: 0.5 ml of serum and/or
each portion extracted is intraperitoneally inoculated in at least two white
mice (20-25 g weight). Positive result is the mice presenting symptoms
within 4-72 h, depending on the amount of toxin injected. Symptoms
include photophobia, difficult or elaborated breathing and death by
respiratory arrest, what does not occur when the heat-treated portion is
inoculated. When the pro-toxin is present, only the activated trypsin
portion would show positive results. In vitro assays based on serological
tests (radioimmunoassay, ELISA) and tissue cultures (human embryonic
lung, HeLa, mouse fibroblast) are available, but the mouse bioassay
remains as the reference test, for its sensitivity and specificity5,11,16,19,20,23.
Botulinum toxin is considered to be the most potent toxin known.
Vaccination of laboratory staff is an important preventive measure, but
it is not always feasible. Because of this, the collection, transport and
investigation of samples must be conducted under strict safety rules.
Samples must be held in an hermetical box, for they not to pose risk for
the personnel responsible for transport and reception of the samples; all
analytical steps must be conduced in a way to prevent aerosol production,
and to preserve the biological structure and function of the toxin. Mouth
pippeting is forbidden; all material that was in contact with the toxin has
to be treated with a 1% chlorine solution. Separate physical area, trained
personal, and adequate animal care (food, water supply) are basic
requirements. Despite the use of an inactivation solution, all material,
including dead animals, should be autoclave sterilized personally by the
responsible investigators, before either disposal or washing. It is strongly
suggested that the phone number and address of sites where antiserum
treatment is performed is at hand, in case of laboratory accident.
Botulinum toxin investigation19 should not be performed by only one
professional working alone.
The objective of this study was to investigate the presence of
botulinum toxin in samples sent to the Instituto Adolfo Lutz, from 1982
to 2001.
MATERIAL AND METHODS
From 1982 to 2001, the Central Laboratory of Food Microbiology
of Instituto Adolfo Lutz, SP, received samples for the investigation of
botulinum toxin from different states of Brazil (Rio de Janeiro, Mato
Grosso do Sul, Minas Gerais, São Paulo, Acre, Goiás Alagoas, Paraná
and Tocantins). Samples were sent to the laboratory for diagnosis of the
disease. The case history (symptoms, time of the onset of symptoms,
ingestion of suspect foods, time between onset of symptoms and
collection of biological samples, administration of antitoxin, etc.) was
not frequently or completely informed to the laboratory.
The samples included food (leftovers from consumption; not
consumed, unopened units of food), drugs (medicines), biological
samples, such as blood, serum or clot, gastric washing, feces and pieces
of organs obtained in the post-mortem examination. The total number of
samples analyzed was 88, among 40 suspect cases or outbreaks as follows:
one in each year of 1982, 1984, 1986, 1989, 1992 and 1994; two in
1985 and 1991; three in 1997; four in 1998; seven in 1999 and 2000;
nine in 2001. FERREIRA et al., 19876, described an outbreak of food
botulism and a case of wound botulism that corresponded to the serum
samples received in 1985, from Minas Gerais.
The bioassay was performed as described in the Compendium of
Methods for the Microbiological Examination of Foods11,20. Briefly,
separated serum from blood (when blood samples were received), serum,
saline solution used to wash the blood clot and organ macerates were
directly injected in two mice, intraperitonially; the other samples (feces,
gastric washing, foods and drugs) were prepared (toxin extraction) and
treated as described by KAUTTER et al., 199211. White Swiss female
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mice (20-25 g each), provided by the Laboratory Animal Facility at
Instituto Adolfo Lutz, were observed closely for the first 6 hours after
inoculation and in 3-4 h intervals, until 72 h. When the bioassay was
positive for toxic substance compatible with botulinum toxin, the
remaining material was submitted to the determination of type of toxin
with specific botulinum antiserum types A, B, E and F. These specific
antisera came from the Centers for Disease Control, Atlanta, United
States. A volume equal to 0.3 ml of antiserum was mixed with 1.2 ml of
the material (serum or extract) and kept at 37 ºC for 30 minutes before
inoculation. For a better observation of the signs and symptoms of animals
- not for toxin quantification - the extracted portion of one of the food
sample was diluted in phosphate gel to 1:100. The investigation was
performed under safety rules already indicated19.
RESULTS AND DISCUSSION
Results obtained in this study are in Table 1. The number of cases /
outbreaks was 40, with 88 samples. From these, 17, corresponding to 8
among the 40 suspect cases/outbreaks (20%), were positive for the
presence of toxin. Fifteen of them were confirmed as type A toxin, and
amount of two samples was not sufficient for the determination of the
type of toxin.
From 36 suspect case/outbreaks, 30 (83.33%) were sent to the
laboratory with some information. Among these 30 cases, 10 (30%)
presented clinical symptoms compatible with botulism. From the other,
two cases presented symptoms compatible with botulism, but with negative
laboratory results. One of these samples was collected ten days after the
onset of symptoms. For the other, samples serum, feces and gastric
washing were collected eight days before the onset of the symptoms;
differential clinical diagnosis indicated nervous blockage of muscle.
Some observations are relevant in relation to data in Table 1. Food
sample from case 5 presented a great quantity of toxin, what led the
sudden death of the mice. The extracted portion had to be diluted to
1:100 for a better observation of the signs and symptoms in the inoculated
animals. The first serum sample received from outbreak 4 was negative,
but the clinical history indicated the administration of antitoxin prior to
blood collection. The second sample of this outbreak came from a fatal
case, from a person who was also affected after the consumption of the
same food. Blood was collected at the moment the patient was admitted
in the hospital and this sample was positive. Case number 5 and 6 were
confirmed in the laboratory examination (toxin was detected both in the
samples of serum and food leftovers). The homemade preserve related
to case 3 was also positive (artichoke hearth, eggs, cucumber, etc.
preserved in oil and vinegar), despite pH equal to 3.8. The finding of
botulism toxin in pH under 4.5 is not new and have already been
reported21,23.
The isolation of Clostridium botulinum from food or biological
samples has a limited value in botulism diagnosis. Because this bacterium
is commonly found in nature and in feces of people not affected, its
isolation should not be considered a significant hazard, or used to
diagnose the disease. The isolation of a toxin-producing C. botulinum
strain is an important tool for the diagnosis of infant botulism, in absence
of normal intestinal flora in babies, and of wound botulism, as it is the
prevalent bacteria in wound material. Even in these cases, definitive
diagnosis is given by the characterization of the toxin circulating in the
bloodstream5,20,23.
Bioassay is an efficient laboratorial tool to determine the presence
of the toxin. As any other laboratorial determination, the whole protocol
must be conducted adequately, in order to assure complete and reliable
results. The amount of sample must be sufficient to perform all laboratory
procedures; the collection of the samples must be related with the time
of the onset of symptoms (ideally, as soon as they begin; or maximum
eight days after the onset). Blood must be collected before the
administration of any drugs that may interfere with laboratorial results,
mainly botulinum antiserum. Transport and preservation of the samples
must be carried out under refrigeration and in hermetic boxes; and the
complete case history related to the sample must be provided, among
other factors.
Table 1
Confirmed botulinum toxin by mouse bioassay, according to the origin, number and kind of sample. Suspect samples were not included. Central Laboratory of
Instituto Adolfo Lutz, 1982-2001
Outbreak or case State Year Number/nature of sample Toxin type
1 M. Gerais 1985 7/serum (1) A
2 M. Gerais 1985 1/serum (1)* A
3 S. Paulo 1991 1/food (leftover of home made preserve) A
4 Goiás 1997 1/serum(2) A
5 S. Paulo 1997 1/blood clot A
1/food (leftovers of palm tree preserve, diluted 1:100) A
6 S. Paulo 1998 1 serum A
1/food (leftover of palm tree preserve) A
7 S. Paulo 1999 1/serum A
8 S. Paulo 2001 1/serum P
1/feces P
(1)Outbreak and case described by FERREIRA et al.6, 1987. * Wound botulism case; (2) First serum was negative (antitoxin administration); second one (fatal case),
was positive; P = Presumptive positive, typification not performed. Result of mouse bioassay compatible with botulinum toxin.
324
GELLI, D.S.; JAKABI, M. & SOUZA, A. - Botulism: a laboratory investigation on biological and food samples from cases and outbreaks in Brazil (1982-2001). Rev. Inst. Med. trop. S. Paulo,
44(6):321-324, 2002
RESUMO
Botulismo: investigação laboratorial de amostras biológicas e de
alimentos de casos e surtos no Brasil (1982-2001)
A investigação laboratorial de botulismo durante 1982-2001,
confirma a ocorrência de surtos/casos de botulismo no Brasil. Dentre
estes, a toxina botulínica tipo A foi encontrada em 7. O material biológico
de 1 caso (soro e fezes) foi positivo para a primeira etapa do bioensaio,
mas a quantidade do material não foi suficiente para a sua tipificação.
Um surto, ocorrido em 2001, foi negativo para a presença de toxina
botulínica em amostras de soro, lavado gástrico e fezes coletadas antes
de 8 dias da instalação dos sintomas na pessoa afetada com diagnóstico
clínico compatível com a doença. Outros 2 casos com diagnóstico clínico
compatível foram negativos, porém nestes a coleta de amostras foi (1)
depois da administração de anti-soro ao paciente e (2) em período superior
a 8 dias do início dos sintomas. A investigação laboratorial foi realizada
por bioensaio em camundongo, conforme descrito no “Compendium of
Methods for the Microbiological Examination of Foods” (compilado
por “American Public Health Association – APHA”)11, e pelo uso de
anti-soros específicos do “Centers for Disease Control (CDC)”, Estados
Unidos.
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